Tirtsah Berger-Peskin

Title: Innovations by Tirtsah Berger-Peskin in Pharmaceutical Development

Introduction

Tirtsah Berger-Peskin, an accomplished inventor based in Raanana, Israel, has made significant contributions to the field of pharmaceuticals. With a focus on innovative formulations, she holds two patents that exemplify her expertise and commitment to improving medical treatments.

Latest Patents

Her most recent patents include the invention titled "Rasagiline Formulations and Processes for Their Preparation." This patent provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate along with a pharmaceutically acceptable carrier. Notably, it specifies the inclusion of greater than 0.7 ppm but less than 30 ppm in total of a compound having a particular structure, as well as any salts of the compound. These formulations are vital in the development of treatments for various neurological conditions.

Career Highlights

Tirtsah is currently affiliated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work involves pioneering developments that impact patient care and therapeutic efficacy. Her contributions not only advance scientific knowledge but also promote better health outcomes.

Collaborations

Throughout her career, Tirtsah has collaborated with esteemed colleagues, including Jeffrey Sterling and David Lerner. These partnerships enhance her innovative projects, fostering an environment where groundbreaking ideas can thrive.

Conclusion

Tirtsah Berger-Peskin's work in the realm of pharmaceutical formulations demonstrates the invaluable impact of innovation in medicine. Her patents reflect her dedication and creativity, propelling advancements that can potentially change lives. As she continues her work at Teva Pharmaceutical Industries Limited, the future looks promising for both her and the field of pharmaceutical innovation.